CANCER OF UNKNOWN PRIMARY
Clinical trials for CANCER OF UNKNOWN PRIMARY explained in plain language.
Never miss a new study
Get alerted when new CANCER OF UNKNOWN PRIMARY trials appear
Sign up with your email to follow new studies for CANCER OF UNKNOWN PRIMARY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for rare cancers: immunotherapy drug targets tumors regardless of origin
Disease control Recruiting nowThis study tests the drug nivolumab in people with advanced rare cancers that have a specific marker (PD-L1). The goal is to see if the drug can shrink or control the tumors when other treatments have stopped working. Up to 28 adults will receive treatment for up to 12 months, an…
Matched conditions: CANCER OF UNKNOWN PRIMARY
Phase: PHASE2 • Sponsor: Instituto do Cancer do Estado de São Paulo • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Stanford launches massive study to track oropharyngeal cancer over time
Knowledge-focused Recruiting nowThis study aims to learn more about oropharyngeal carcinoma, a type of throat cancer that can be linked to HPV. Researchers will collect blood samples from 1,000 patients before treatment and at six follow-up visits, and also gather tumor tissue when available. The goal is to bet…
Matched conditions: CANCER OF UNKNOWN PRIMARY
Sponsor: Stanford University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:06 UTC
-
Blood test could unlock new treatments for mysterious cancer
Knowledge-focused Recruiting nowCancer of Unknown Primary (CUP) is a rare cancer where doctors cannot find where it started, and it is often deadly within months. This study will test a blood-based genomic test in 100 people with CUP to see if it can find genetic changes that point to new treatment options. The…
Matched conditions: CANCER OF UNKNOWN PRIMARY
Sponsor: The Christie NHS Foundation Trust • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:00 UTC